Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q27
SBA

SBA — Single Best Answer · Review

Question 27

Feto-maternal medicine → Perinatology

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID e5239d7d-e161-45d2-924f-c7a30a56160a

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Feto-maternal medicine
Topic
Perinatology
Subtopic 1
Diagnosis
Subtopic 2
Invasive
Subtopic 3
Blood-borne viruses
Question Type
SBA

Question

SSBA
Question Header
Maternal HIV status
Question Stem
A pregnant woman requires invasive prenatal diagnosis, but her HIV status is not yet known. What is the most appropriate management before proceeding?

Options

A Proceed immediately because HIV status does not affect invasive testing
B Delay invasive testing until her HIV status is known
C Perform CVS rather than amniocentesis regardless of gestation
D Administer antibiotics and proceed
E Avoid all prenatal diagnostic testing for the remainder of pregnancy

Explanation

When maternal HIV status is unknown, RCOG advises delaying invasive prenatal testing until the result is available. In women living with HIV, transmission risk should be assessed in the context of antiretroviral therapy and viral load. When a woman is receiving effective combination antiretroviral treatment and has an undetectable viral load, mother-to-child transmission risk is very low, but management should still be individualised.

Option Validity

A) Maternal HIV status is relevant when assessing the transmission risk associated with invasive testing.

C) CVS is not automatically safer and its use depends on gestation and clinical indication.

D) Antibiotic administration does not substitute for determining maternal HIV status and assessing viral transmission risk.

E) Invasive diagnosis is not universally contraindicated in women living with HIV; management is individualised according to treatment and viral load.

Further Reading

Navaratnam K, Alfirevic Z; Royal College of Obstetricians and Gynaecologists. Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8. BJOG. 2022;129:e1-e15.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
9.50
Destination
Site
Source
Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8
Source Section
Blood-borne viral infection
Source Locator
RCOG Green-top Guideline No. 8, October 2021
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question